180 related articles for article (PubMed ID: 24739387)
1. A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.
Ugarte-Berzal E; Bailón E; Amigo-Jiménez I; Albar JP; García-Marco JA; García-Pardo A
J Biol Chem; 2014 May; 289(22):15340-9. PubMed ID: 24739387
[TBL] [Abstract][Full Text] [Related]
2. A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.
Ugarte-Berzal E; Bailón E; Amigo-Jiménez I; Vituri CL; del Cerro MH; Terol MJ; Albar JP; Rivas G; García-Marco JA; García-Pardo A
J Biol Chem; 2012 Aug; 287(33):27601-13. PubMed ID: 22730324
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MMP-9-dependent Degradation of Gelatin, but Not Other MMP-9 Substrates, by the MMP-9 Hemopexin Domain Blades 1 and 4.
Ugarte-Berzal E; Vandooren J; Bailón E; Opdenakker G; García-Pardo A
J Biol Chem; 2016 May; 291(22):11751-60. PubMed ID: 27044750
[TBL] [Abstract][Full Text] [Related]
4. Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.
Redondo-Muñoz J; Ugarte-Berzal E; García-Marco JA; del Cerro MH; Van den Steen PE; Opdenakker G; Terol MJ; García-Pardo A
Blood; 2008 Jul; 112(1):169-78. PubMed ID: 18326820
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain.
Redondo-Muñoz J; Ugarte-Berzal E; Terol MJ; Van den Steen PE; Hernández del Cerro M; Roderfeld M; Roeb E; Opdenakker G; García-Marco JA; García-Pardo A
Cancer Cell; 2010 Feb; 17(2):160-72. PubMed ID: 20159608
[TBL] [Abstract][Full Text] [Related]
7. Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides.
Dufour A; Zucker S; Sampson NS; Kuscu C; Cao J
J Biol Chem; 2010 Nov; 285(46):35944-56. PubMed ID: 20837483
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
Amigo-Jiménez I; Bailón E; Ugarte-Berzal E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
PLoS One; 2014; 9(6):e99993. PubMed ID: 24956101
[TBL] [Abstract][Full Text] [Related]
9. MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest.
Aguilera-Montilla N; Bailón E; Uceda-Castro R; Ugarte-Berzal E; Santos A; Gutiérrez-González A; Pérez-Sánchez C; Van den Steen PE; Opdenakker G; García-Marco JA; García-Pardo A
Oncogene; 2019 Jun; 38(23):4605-4619. PubMed ID: 30760844
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
Bailón E; Ugarte-Berzal E; Amigo-Jiménez I; Van den Steen P; Opdenakker G; García-Marco JA; García-Pardo A
J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557
[TBL] [Abstract][Full Text] [Related]
11. Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins.
Stefanidakis M; Bjorklund M; Ihanus E; Gahmberg CG; Koivunen E
J Biol Chem; 2003 Sep; 278(36):34674-84. PubMed ID: 12824186
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.
Zarrabi K; Dufour A; Li J; Kuscu C; Pulkoski-Gross A; Zhi J; Hu Y; Sampson NS; Zucker S; Cao J
J Biol Chem; 2011 Sep; 286(38):33167-77. PubMed ID: 21795678
[TBL] [Abstract][Full Text] [Related]
13. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration.
Redondo-Muñoz J; Escobar-Díaz E; Samaniego R; Terol MJ; García-Marco JA; García-Pardo A
Blood; 2006 Nov; 108(9):3143-51. PubMed ID: 16840734
[TBL] [Abstract][Full Text] [Related]
14. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration.
Redondo-Muñoz J; José Terol M; García-Marco JA; García-Pardo A
Blood; 2008 Jan; 111(1):383-6. PubMed ID: 17890452
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy.
Yosef G; Hayun H; Papo N
Biochem J; 2021 Mar; 478(5):1139-1157. PubMed ID: 33600567
[TBL] [Abstract][Full Text] [Related]
17. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
Dufour A; Sampson NS; Zucker S; Cao J
J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
[TBL] [Abstract][Full Text] [Related]
18. VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration.
Ugarte-Berzal E; Redondo-Muñoz J; Eroles P; Del Cerro MH; García-Marco JA; Terol MJ; García-Pardo A
Blood; 2010 Jan; 115(4):846-9. PubMed ID: 19965686
[TBL] [Abstract][Full Text] [Related]
19. Membrane localization of membrane type 1 matrix metalloproteinase by CD44 regulates the activation of pro-matrix metalloproteinase 9 in osteoclasts.
Chellaiah MA; Ma T
Biomed Res Int; 2013; 2013():302392. PubMed ID: 23984338
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil elastase cleavage of the gC1q domain impairs the EMILIN1-α4β1 integrin interaction, cell adhesion and anti-proliferative activity.
Maiorani O; Pivetta E; Capuano A; Modica TM; Wassermann B; Bucciotti F; Colombatti A; Doliana R; Spessotto P
Sci Rep; 2017 Jan; 7():39974. PubMed ID: 28074935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
